Highly absorbent bio-sponge based on carboxymethyl chitosan/poly-γ-glutamic acid/platelet-rich plasma for hemostasis and wound healing

Int J Biol Macromol. 2023 Aug 30:247:125754. doi: 10.1016/j.ijbiomac.2023.125754. Epub 2023 Jul 8.

Abstract

Stopping bleeding at an early stage and promoting wound healing are of great significance for efficient wound management. In this study, a carboxymethyl chitosan (CMCS)/poly-γ-glutamic acid (γ-PGA)/platelet-rich plasma (PRP) hydrogel (CP-PRP hydrogel) was firstly prepared by crosslinking of CMCS with γ-PGA and the enzymatic coagulation of PRP. Then, the CP-PRP hydrogel was freeze-dried and transformed into a sponge (CP-PRP sponge). A series of safety experiments with cells, blood, and tissues proved the biocompatibility of the CP-PRP sponge. Importantly, the CP-PRP sponge was able to adhere and condense red blood cells, which accelerated blood clotting. Therefore, the CP-PRP sponge showed an enhanced hemostasis effect compared to SURGIFLO® Hemostatic Matrix. Moreover, in vitro and in vivo experiments showed that the sponge was able to release epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF). Thus, in a mouse model of full-thickness skin defects, the wounds of the sponge-treated mice were significantly healed within two weeks. These results proved the transforming potential of the CP-PRP sponge as a novel bioactive wound dressing.

Keywords: Carboxymethyl chitosan; Hemostasis; Platelet-rich plasma; Poly-γ-glutamic acid; Wound healing.

MeSH terms

  • Animals
  • Bandages
  • Chitosan*
  • Glutamic Acid
  • Hemostasis
  • Hydrogels / pharmacology
  • Mice
  • Platelet-Rich Plasma*
  • Vascular Endothelial Growth Factor A
  • Wound Healing

Substances

  • Chitosan
  • Glutamic Acid
  • Vascular Endothelial Growth Factor A
  • Hydrogels